Showing results (61-70 of 176) with videos related to

Sort By:
Pageof 18
Journal of Hepatology|December 15, 2010
IL28 variation affects expression of interferon stimulated genes and peg-interferon and ribavirin therapyHiromi Abe, C Nelson Hayes, Hidenori Ochi, et al.
Antiviral Therapy|July 28, 2012
Identification of novel HCV deletion mutants in chronic hepatitis C patientsTomohiko Kohno, Masataka Tsuge, C Nelson Hayes, et al.
Journal of Gastroenterology|February 12, 2013
Serum HBV RNA and HBeAg are useful markers for the safe discontinuation of nucleotide analogue treatments in chronic hepatitis B patientsMasataka Tsuge, Eisuke Murakami, Michio Imamura, et al.
Scientific Reports|June 13, 2019
Regulation of the Hepatitis B virus replication and gene expression by the multi-functional protein TARDBPGrace Naswa Makokha, Hiromi Abe-Chayama, Sajeda Chowdhury, et al.
Antiviral Therapy|November 13, 2015
Combination therapies with daclatasvir and asunaprevir on NS3-D168 mutated HCV in human hepatocyte chimeric miceHiromi Kan, Nobuhiko Hiraga, Michio Imamura, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|October 7, 2015
Three patients treated with daclatasvir and asunaprevir for recurrent hepatitis C after liver transplantation: Case reportTomokazu Kawaoka, Michio Imamura, Kei Morio, et al.
International Journal of Molecular Sciences|October 29, 2025
Utility of Serum HBV RNA Measurement During Nucleoside/Nucleotide Analog Therapy in Chronic Hepatitis B PatientsKeiichi Hiraoka, Masataka Tsuge, Michihiko Kawahara, et al.
Pageof 18